HYPERTENSION DIAGNOSTICS INC /MN 4
4 · HYPERTENSION DIAGNOSTICS INC /MN · Filed Oct 12, 2010
Insider Transaction Report
Form 4
HOEKSTRA MARTEN
10% Owner
Transactions
- Disposition to Issuer
Preferred Stock Warrant
2010-10-01−44,799→ 0 totalExercise: $3.60Exp: 2010-09-30→ Preferred Stock (44,799 underlying) - Award
Preferred Stock Warrant
2010-10-01+44,799→ 44,799 totalExercise: $3.60Exp: 2011-09-30→ Preferred Stock (44,799 underlying) - Disposition to Issuer
Common Stock Warrant
2010-10-01−407,105→ 0 totalExercise: $0.22Exp: 2010-09-30→ Common Stock (407,105 underlying) - Award
Common Stock Warrant
2010-10-01+712,433→ 712,433 totalExercise: $0.30Exp: 2011-09-30→ Common Stock (712,433 underlying) - Disposition to Issuer
Preferred Stock Warrant
2010-10-01−25,599.5→ 0 totalExercise: $2.64Exp: 2010-09-30→ Preferred Stock (25,599.5 underlying) - Award
Common Stock Warrant
2010-10-01+407,105→ 407,105 totalExercise: $0.22Exp: 2011-09-30→ Common Stock (407,105 underlying) - Award
Preferred Stock Warrant
2010-10-01+25,599.5→ 25,599.5 totalExercise: $2.64Exp: 2011-09-30→ Preferred Stock (25,599.5 underlying) - Disposition to Issuer
Preferred Stock Warrant
2010-10-05−44,799→ 0 totalExercise: $3.60Exp: 2011-09-30→ Preferred Stock (44,799 underlying) - Disposition to Issuer
Common Stock Warrant
2010-10-05−151,708→ 560,725 totalExercise: $0.30Exp: 2011-09-30→ Common Stock (151,708 underlying) - Disposition to Issuer
Common Stock Warrant
2010-10-01−712,433→ 0 totalExercise: $0.30Exp: 2010-09-30→ Common Stock (712,433 underlying)
Footnotes (8)
- [F1]As reported in the issuer's Annual Report on Form 10-K filed on September 24, 2010, in July 2010 the issuer extended the expiration date on all outstanding warrants of this type from September 30, 2010 to September 30, 2011. As a result, the reported transactions involve an amendment of outstanding warrants, resulting in the deemed cancellation of the "old" warrants and the grant of replacement warrants.
- [F2]As reported in the issuer's Annual Report on Form 10-K filed on September 24, 2010, in July 2010 the issuer extended the expiration date on all outstanding warrants of this type from September 30, 2010 to September 30, 2011. As a result, the reported transactions involve an amendment of outstanding warrants, resulting in the deemed cancellation of the "old" warrants and the grant of replacement warrants.
- [F3]As reported in the issuer's Annual Report on Form 10-K filed on September 24, 2010, in July 2010 the issuer extended the expiration date on all outstanding warrants of this type from September 30, 2010 to September 30, 2011. As a result, the reported transactions involve an amendment of outstanding warrants, resulting in the deemed cancellation of the "old" warrants and the grant of replacement warrants.
- [F4]As reported in the issuer's Annual Report on Form 10-K filed on September 24, 2010, in July 2010 the issuer extended the expiration date on all outstanding warrants of this type from September 30, 2010 to September 30, 2011. As a result, the reported transactions involve an amendment of outstanding warrants, resulting in the deemed cancellation of the "old" warrants and the grant of replacement warrants.
- [F5]As reported in the issuer's Annual Report on Form 10-K filed on September 24, 2010, in February 2010 the issuer temporarily modified the exercise price on all outstanding warrants of this type from $0.22 to $0.14. The issuer reported in the Form 10-K that such temporary price reduction is still in effect.
- [F6]As reported in the issuer's Annual Report on Form 10-K filed on September 24, 2010, in February 2010 the issuer temporarily modified the exercise price on all outstanding warrants of this type from $2.64 to $1.68. The issuer reported in the Form 10-K that such temporary price reduction is still in effect.
- [F7]These warrants were assigned by the Reporting Person to the issuer for no value.
- [F8]These warrants are immediately exercisable and remain exercisable until expiration.